Merck KGaA / Key word(s): Change of Personnel
18.09.2014 10:11
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Merck Strengthens Executive Board
Merck hereby announces that today E. Merck KG has appointed Stefan Oschmann
(57) to the position of Vice Chairman and Deputy CEO. Concurrently, Belén
Garijo (54) has been appointed to the Executive Board to take over
leadership for the Pharma business. The management changes will be
effective as of January 1, 2015.
Oschmann, currently CEO Pharma, will represent Karl-Ludwig Kley, Chief
Executive Officer and Chairman of the Executive Board, in his
responsibilities. Both will share strategic management functions and
represent the company with politicians and international organizations. As
a member of the Executive Board, Garijo, currently CEO of Merck's
biopharmaceutical division Merck Serono, will take on responsibility for
the whole Pharma business, which in addition to Merck Serono comprises
Consumer Health, Allergy and Biosimilars.
18.09.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany
Phone: +49 (0)6151 72 - 3321
Fax: +49 (0)6151 72 - 913321
E-mail: investor.relations@merckgroup.com
Internet: www.merck.de
ISIN: DE0006599905
WKN: 659990
Indices: DAX
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart;
Terminbörse EUREX; London, SIX
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: Merck KGaA: Merck Strengthens Executive Board
| Source: EQS Group AG